XML 12 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Net Loss and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue $ 80,879,000 $ 55,855,000
Cost of sales 63,418,000 53,635,000
Gross profit 17,461,000 2,220,000
Operating expenses    
Research and development 67,509,000 48,012,000
Selling, general and administrative 45,620,000 12,752,000
Total operating expenses 113,129,000 60,764,000
Loss from operations (95,668,000) (58,544,000)
Other expense    
Change in fair value of warrant liability (3,684,000) 3,073,000
Interest Income 5,974,000 1,028,000
Interest expense (3,605,000) (6,192,000)
Gain on settlement of contingent liabilities 381,000 0
Other (expense) income, net (7,000) 542,000
Total other expense, net (941,000) (1,549,000)
Loss before provision for income taxes (96,609,000) (60,093,000)
Provision for income taxes (67,000) 0
Net loss and comprehensive loss (96,676,000) (60,093,000)
Net loss available to common stockholders, basic (96,676,000) (72,281,000)
Net loss available to common stockholders, diluted $ (96,676,000) $ (72,281,000)
Net loss per common share    
Basic $ (0.61) $ (5.38)
Diluted $ (0.61) $ (5.38)
Weighted-average common shares outstanding    
Basic 159,639 13,442
Diluted 159,639 13,442
Series C Preferred Stock    
Other expense    
Less: Accretion of dividends $ 0 $ (5,579,000)
Series D-1 Preferred Stock    
Other expense    
Less: Accretion of dividends $ 0 $ (6,609,000)